Notch1 regulates hepatic thrombopoietin production

Area of Science:

• Cell Biology
• Developmental Biology
• Hematology

Background:

• Notch signaling is vital for cell fate decisions.
• Its role in hepatic thrombopoietin (TPO) production is not well understood.
• Thrombocytopenia was observed in mice with hepatic Notch1 deficiency.

Purpose of the Study:

• To investigate the role of Notch1 in hepatic TPO production.
• To elucidate the underlying molecular mechanisms.
• To explore potential therapeutic targets for modulating TPO levels.

Main Methods:

• Analysis of liver ultrastructure and hepatocyte function in Notch1-deficient mice.
• Measurement of plasma and hepatic TPO levels (mRNA and protein).
• Assessment of platelet counts, megakaryocyte differentiation, and JAK2/STAT3 phosphorylation.
• In vitro studies using cultured hepatocytes and desialylated platelets.
• Investigation of Ashwell-Morell receptor (AMR) and Delta-like 4 interactions.

Main Results:

• Notch1 deficiency led to significantly lower plasma TPO and hepatic TPO mRNA levels.
• Platelet counts and megakaryocyte differentiation were impaired in deficient mice, but rescued by exogenous TPO.
• JAK2/STAT3 phosphorylation was inhibited in Notch1-deficient hepatocytes.
• Desialylated platelets activated Notch1 signaling via HES5, promoting JAK2/STAT3 phosphorylation and TPO production.
• Hepatocyte Ashwell-Morell receptor (AMR) physically associates with Notch1, and its inhibition impaired Notch1 signaling and TPO production.
• Blocking Delta-like 4 on desialylated platelets inhibited Notch1 activation and downstream signaling.

Conclusions:

• Notch1 plays a critical regulatory role in hepatic TPO production.
• The Notch1-JAK2/STAT3 pathway, modulated by desialylated platelets via AMR and HES5, is essential for TPO synthesis.
• Notch1 represents a potential therapeutic target for managing TPO levels and related conditions.